Kidney Stone Analysis and Metabolic Stone Screen
Stone analysis identifies the chemical composition of a calculus passed or removed from the urinary tract, using infrared spectroscopy or X-ray diffraction, which are more accurate than chemical methods. The metabolic stone screen measures the blood and urine factors that promote stones: serum calcium, phosphate, uric acid, creatinine, bicarbonate and parathyroid hormone, and on two 24-hour urine collections the volume, calcium, oxalate, citrate, uric acid, sodium, magnesium, phosphate, pH and cystine.
The combined results classify the stone type, find the underlying disorder and select preventive treatment. Recurrence is high, with about 50% of patients having another stone within 5 to 10 years, so evaluation is indicated after a first stone in higher risk patients and after every recurrence.
Kidney stones affect 5 to 10% of the world population, with a lifetime risk of 10 to 15% in men and 5 to 7% in women, and the prevalence is rising with obesity, diabetes and hot climates. Calcium oxalate stones make up 70 to 80% of stones, calcium phosphate 5 to 10%, uric acid 5 to 10%, struvite 2 to 15% and cystine 1%.
Indications. All children with a stone, recurrent stones, a first stone in men and women at high risk (family history, young age, solitary kidney, bilateral stones, nephrocalcinosis, bowel disease, bariatric surgery, gout, kidney impairment, osteoporosis or hypercalcaemia), and any stone when the composition is unknown.
Specimen. The stone (strained from urine or recovered at surgery) in a dry container, not in formalin. For the metabolic screen, two consecutive 24-hour urine collections on the usual diet, started at least 4 to 6 weeks after an acute stone episode. Use acid or thymol preservative as the laboratory advises for calcium, oxalate and citrate, and no preservative for uric acid and pH. Blood tests are taken fasting.













